Tuberculosis, Meningeal
Information
- Disease name
- Tuberculosis, Meningeal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02169882 | Completed | Phase 2/Phase 3 | High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study | December 1, 2014 | May 5, 2017 |
NCT02958709 | Completed | Phase 1/Phase 2 | Optimizing Treatment to Improve TBM Outcomes in Children | February 22, 2017 | November 15, 2020 |
NCT03537495 | Completed | Phase 2 | Pharmacokinetic Study of Linezolid for TB Meningitis | June 21, 2021 | July 20, 2023 |
NCT04021121 | Completed | Phase 2 | Adjunctive Linezolid for the Treatment of Tuberculous Meningitis | May 5, 2021 | December 4, 2023 |
NCT06446245 | Not yet recruiting | Phase 2 | Adjunctive Doxycycline for Central Nervous System Tuberculosis | July 2024 | December 2027 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014390